Theo B.A. Mulder

Determination of Picomole Amounts of Dopamine, Noradrenaline, 3,4‐Dihydroxyphenylalanine, 3,4‐Dihydroxyphenylacetic Acid, Homovanillic Acid, and 5‐Hydroxyindolacetic Acid in Nervous Tissue After One‐Step Purification on Sephadex G‐10, Using High‐Performance Liquid Chromatography with a Novel Type of Electrochemical Detection

Ben H.C. Westerink, Theo B.A. Mulder · Journal of Neurochemistry · 1981 · 166 citations

Pharmacy, Biochemistry, Pharmacology +16

Synthesis and pharmacology of trans-4-n-propyl-3,4,4a,10b-tetrahydro-2H,5H-1-benzopyrano[4,3-b]1,4-oxazin-7- and -9-ols. The significance of nitrogen pka values for central dopamine receptor activation

Durk Dijkstra, Theo B.A. Mulder, Hans Rollema et al. · Journal of Medicinal Chemistry · 1988 · 32 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

The significance of COMT activity in controlling dopamine agonist levels in brain and serum: Studies with a prodrug and a metabolite of 6,7-ADTN

Hans Rollema, Ben H.C. Westerink, Theo B.A. Mulder et al. · European Journal of Pharmacology · 1980 · 27 citations

Medicine, Neuroscience, Pharmacology +14

In vivo dopamine receptor binding studies with a non-radioactively labeled agonist, dipropyl-5, 6-ADTN

Matthijs G.P. Feenstra, Hans Rollema, Theo B.A. Mulder et al. · Life Sciences · 1983 · 25 citations

Medicine, Neuroscience, Pharmacology +14

Further in vitro and in vivo studies with the putative presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin

Theo B.A. Mulder, Jan B. De Vries, Durk Dijkstra et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1987 · 20 citations

Life Sciences, Neuroscience, Pharmacology +14